Lili Hu

OTT_A_200601 5135..5142

Ji-Feng Wu, Jianxia Zhou, Xin-Ai Li, 2019 .

Statin use and endometrial cancer risk: a meta-analysis

Qiao Liu, Jing Yang, Weimin Xie, 2017, Oncotarget.

An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer.

B. Monk, Xinhua Yu, J. Chan, 2012, Gynecologic oncology.

The safety and efficacy of amrubicin in the treatment of previously untreated extensive-disease small-cell lung cancer: a meta-analysis

Ji-Feng Wu, Jianxia Zhou, Xin-Ai Li, 2019, OncoTargets and therapy.

Bevacizumab in treatment of high-risk ovarian cancer--a cost-effectiveness analysis.

B. Monk, Xinhua Yu, J. Chan, 2014, The oncologist.

An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer.

B. Monk, Xinhua Yu, J. Chan, 2012, Gynecologic oncology.